API Product   :    Moxifloxacin HCI
CEP   :    ¤
WCC   :    ?
Therapeutic Use    :    Topical antibacterials and antivirals; Ophthalmological/Otological Combinations; Ophthalmologicals; Systemic antibacterials
Topical antibacterials and antivirals; Ophthalmological/Otological Combinations; Ophthalmologicals; Systemic antibacterials
Originator   :    Merck Sharp & Dohme
Merck Sharp & Dohme
CAS No.    :    354812-41-2
Trade Name.   :    AVELOX
Molecular Weight   :    401.431 g/mol
Molecular Formula   :    C21H24FN3O4
Moxifloxacin hydrochloride is an antibiotic prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain bacterial infections, such as acute worsening of chronic bronchitis; pneumonia; plague; and skin, abdominal, and acute sinus infections.
Moxifloxacin, sold under the brandname Avelox among others, is an antibiotic used to treat a number of bacterial infections. This includes pneumonia, conjunctivitis, endocarditis, tuberculosis, and sinusitis. It is used by mouth, by injection into a vein, or as an eye drop. Common side effects include diarrhea, dizziness, and headache. Severe side effects may include spontaneous tendon ruptures, nerve damage, and worsening of myasthenia gravis. Safety of use in pregnancy or breastfeeding is unclear. Moxifloxacin is in the fluoroquinolone family of medications. It usually results in bacterial death through blocking their ability to duplicate DNA.